Sarepta Therapeutics, Inc. (SRPT)
16.68
0.00 (0.00%)
USD |
NASDAQ |
May 27, 16:00
16.75
+0.08
(+0.45%)
After-Hours: 19:38
Sarepta Therapeutics Total Assets (Quarterly) : 3.179B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 2.869B |
| Keros Therapeutics, Inc. | 312.29M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| REGENXBIO, Inc. | 341.89M |
| Biogen, Inc. | 29.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.674B |
| Shareholders Equity (Quarterly) | 1.505B |
| Debt to Equity Ratio | 0.6888 |
| Current Ratio | 4.628 |
| Net Debt Paydown Yield | 2.67% |